Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alan S Perlman, M.D.
The Rogosin Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Rogosin Institute
New York, New York, United States
Alan S Perlman, MDCholi Hartono, MDDaniel M Levine, PhDDavid Serur, MDJames M Chevalier, MDJohn CL Wang, MDJun Lee, MDLiu M Frank, MDManikkam Suthanthiran, MDMeredith J Aull, PharmDNathaniel Berman, MDNelson Chen, CRCSurya V Seshan, MDThomas S Parker, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2013
- Primary completion
- 31 Aug 2028
- Completion
- 31 Aug 2028
- Last update posted
- 4 Apr 2025
- Registered enrollment
- 2,000
- Registry id
- NCT01802034
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.